Teva Pharmaceutical Industries
TEVA
#639
Rank
โ‚ฌ33.55 B
Marketcap
28,81ย โ‚ฌ
Share price
-1.11%
Change (1 day)
74.98%
Change (1 year)

Revenue for Teva Pharmaceutical Industries (TEVA)

Revenue in 2025 (TTM): โ‚ฌ14.96 Billion

According to Teva Pharmaceutical Industries's latest financial reports the company's current revenue (TTM ) is โ‚ฌ14.64 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ15.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Teva Pharmaceutical Industries from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ14.69 B-7.59%
2024 โ‚ฌ15.89 B10.91%
2023 โ‚ฌ14.33 B3.03%
2022 โ‚ฌ13.91 B-0.77%
2021 โ‚ฌ14.02 B3.53%
2020 โ‚ฌ13.54 B-7.54%
2019 โ‚ฌ14.64 B-11.13%
2018 โ‚ฌ16.48 B-11.9%
2017 โ‚ฌ18.70 B-10.16%
2016 โ‚ฌ20.82 B15.86%
2015 โ‚ฌ17.97 B7.83%
2014 โ‚ฌ16.66 B13.32%
2013 โ‚ฌ14.70 B-4.23%
2012 โ‚ฌ15.35 B8.93%
2011 โ‚ฌ14.10 B16.34%
2010 โ‚ฌ12.11 B24.93%
2009 โ‚ฌ9.70 B22.35%
2008 โ‚ฌ7.92 B23.06%
2007 โ‚ฌ6.44 B1.11%
2006 โ‚ฌ6.37 B43.78%
2005 โ‚ฌ4.43 B25.29%
2004 โ‚ฌ3.53 B35.94%
2003 โ‚ฌ2.60 B8.01%
2002 โ‚ฌ2.40 B2.43%
2001 โ‚ฌ2.35 B26.63%
2000 โ‚ฌ1.85 B45.75%
1999 โ‚ฌ1.27 B35.52%
1998 โ‚ฌ0.94 B-0.09%
1997 โ‚ฌ0.94 B17.1%
1996 โ‚ฌ0.80 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ48.09 B 228.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ53.28 B 263.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.33 B 175.38%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ54.51 B 272.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.33 B 236.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ35.94 B 145.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
โ‚ฌ3.35 B-77.08%๐Ÿ‡ฎ๐Ÿ‡ณ India